Enliven Therapeutics, Inc. (NASDAQ:ELVN) is held by 126 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 7,959,538 | 0 | 0.00% | $312,013,890.00 |
| FMR LLC | 31 Mar, 2026 | 6,829,246 | -278,389 | -3.92% | $267,706,443.00 |
| Polar Capital Holdings Plc | 31 Mar, 2026 | 5,065,933 | 1,552,253 | 44.18% | $198,584,574.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,684,707 | 71,381 | 1.98% | $144,440,514.00 |
| Commodore Capital LP | 31 Mar, 2026 | 3,275,000 | -1,417,809 | -30.21% | $128,380,000.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 3,250,000 | -580,000 | -15.14% | $127,400,000.00 |
| Bellevue Group AG | 31 Mar, 2026 | 2,320,867 | 2,320,867 | 0.00% | $90,977,986.00 |
| Fairmount Funds Management LLC | 31 Mar, 2026 | 1,855,644 | -1,855,800 | -50.00% | $72,741,245.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,743,915 | 319,571 | 22.44% | $68,361,468.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 1,726,331 | -1,500,000 | -46.49% | $67,672,175.00 |
| Novo Holdings A/S | 31 Mar, 2026 | 1,280,000 | -200,000 | -13.51% | $50,176,000.00 |
| State Street Corp | 31 Mar, 2026 | 1,091,106 | 38,244 | 3.63% | $42,771,355.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,066,420 | 17,698 | 1.69% | $41,813,049.00 |
| Pictet Asset Management Holding SA | 31 Mar, 2026 | 929,544 | -373,691 | -28.67% | $36,438,125.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 905,191 | 633,785 | 233.52% | $35,483,487.00 |
| Rock Springs Capital Management LP | 31 Mar, 2026 | 826,500 | 28,095 | 3.52% | $32,398,800.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 771,885 | 735,045 | 1,995.24% | $11,887,029.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 746,226 | 746,226 | 0.00% | $29,252,059.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 681,715 | 282,822 | 70.90% | $26,714,134.00 |
| First Turn Management, LLC | 31 Mar, 2026 | 623,839 | 623,839 | 0.00% | $24,454,489.00 |